Dr. Eskil Eskilsson, PhD

Dr. Eskil Eskilsson

PhD

San Francisco Bay Area, CA | United States

Dr. Eskil Eskilsson, PhD

Dr. Eskil Eskilsson

PhD
Introduction
Metrics

5

Publications

692

Profile Views

46

Reads

61

PubMed Central Citations

Top co-authors
Hrvoje Miletic
Hrvoje Miletic

University of Bergen

4
Rolf Bjerkvig
Rolf Bjerkvig

University of Bergen

3
Krishna M Talasila
Krishna M Talasila

University of Bergen

3
Jubayer Al Hossain
Jubayer Al Hossain

University of Bergen

2
Gro V Rosland
Gro V Rosland

University of Bergen

2
Simone P Niclou
Simone P Niclou

NorLux Neuro-Oncology Laboratory

2
Philipp Euskirchen
Philipp Euskirchen

University of Bergen

2
Justin V Joseph
Justin V Joseph

University of Groningen

2
Morten Lund-Johansen
Morten Lund-Johansen

University of Bergen

2
Patrick N Harter
Patrick N Harter

Goethe University

2

Publications

5Publications

46Reads

61PubMed Central Citations

EGFRvIII mutations can emerge as late and heterogenous events in glioblastoma development and promote angiogenesis through Src activation.

Neuro Oncol 2016 12 10;18(12):1644-1655. Epub 2016 Jun 10.

Department of Biomedicine, University of Bergen, Norway (E.E., G.V.R., K.M.T., O.K., T.T., K.V., J.A.H., J.V.J., R.J., H.S.S., L.L., T.D., P.Ø.E., R.B., H.M.); KG Jebsen Brain Tumor Research Center, University of Bergen, Norway (E.E., G.V.R., K.M.T., O.K., K.V., J.A.H., J.V.J., T.D., P. Ø.E., S.P.N., R.B., H.M.); Department of Clinical Science, University of Bergen, Norway (S.K.); Department of Oncology, Haukeland University Hospital, Bergen, Norway (S.K.); Norlux Neuro-Oncology Laboratory, Department of Oncology, Luxembourg Institute of Health, Luxembourg (O.K., S.F., S.P.N., R.B.); Centre for Evolution and Cancer, The Institute of Cancer Research, London, UK (A.S.); Department of Clinical Pharmacy, Institute of Pharmacy, Ernst-Moritz-Arndt-University, Greifswald, Germany (S.F., C.A.R.); Department of Neurooncology, University Hospital Heidelberg, Germany (G.S., F.W.); Institute of Scientific Instruments, ASCR, Brno, Czech Republic (R.J.); Edinger-Intsitute, Goethe-University Medical School, Frankfurt am Main, Germany (P.N.H.); Department of Pathology, Haukeland University Hospital, Bergen, Norway (J.A.H., H.M.); Department of Clinical Neurosciences, University of Cambridge, UK (S.G.P., C.W.); Statistics and Computational Biology Laboratory, University of Cambridge, UK (I.S.); Neuro Clinic, Haukeland University Hospital, Bergen, Norway; Department of Experimental Neurology, Charité - Universitätsmedizin Berlin, Germany (P.E.); Department of Systems Medicine, University of Rome «Tor Vergata», Rome, Italy (G.G.); INSERM U1029 - University of Bordeaux, Allée Geoffroy St. Hilaire, Pessac, France (T.D.); Department of Neurosurgery, Haukeland University Hospital, Bergen, Norway (M.L.-J., P. Ø.E.).

View Article
December 2016
16 Reads
9 PubMed Central Citations(source)
5.56 Impact Factor

Longitudinal genomic characterization of brain tumors for identification of therapeutic vulnerabilities.

Neuro Oncol 2016 08 28;18(8):1037-9. Epub 2016 May 28.

Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas (E.E., R.G.W.V.); Department of Bioinformatics and Computational Biology, The University of Texas MD Anderson Cancer Center, Houston, Texas (R.G.W.V.).

View Article
August 2016
1 PubMed Central Citation(source)
5.56 Impact Factor

Pim1 kinase is upregulated in glioblastoma multiforme and mediates tumor cell survival.

Neuro Oncol 2015 Feb 25;17(2):223-42. Epub 2014 Aug 25.

Department of Pharmacology/C_DAT (S.H., M.H., M.A.F., T.H., A.B., H.E.M.z.S., H.K.K., B.R., S.B-M.); Institute of Pathology (S.V.); Institute of Pharmacy (C.A.R.); Institute for Community Medicine (K.W., C.H., W.H.); Clinic of Neurosurgery (C.F., M.F., H.S.); Institute of Radiology and Neuroradiology, Universitätsmedizin Greifswald, Greifswald, Germany (S.H., K.K., S.L.); Department of Biomedicine, University of Bergen, Bergen, Norway (E.E., H.M.); Department of Pathology, Haukeland University Hospital, Bergen, Norway (E.E., H.M.).

View Article
February 2015
13 Reads
3 PubMed Central Citations(source)
5.56 Impact Factor
Top co-authors
Hrvoje Miletic
Hrvoje Miletic

University of Bergen

4
Rolf Bjerkvig
Rolf Bjerkvig

University of Bergen

3
Krishna M Talasila
Krishna M Talasila

University of Bergen

3
Jubayer Al Hossain
Jubayer Al Hossain

University of Bergen

2
Gro V Rosland
Gro V Rosland

University of Bergen

2
Simone P Niclou
Simone P Niclou

NorLux Neuro-Oncology Laboratory

2
Philipp Euskirchen
Philipp Euskirchen

University of Bergen

2
Justin V Joseph
Justin V Joseph

University of Groningen

2
Morten Lund-Johansen
Morten Lund-Johansen

University of Bergen

2
Patrick N Harter
Patrick N Harter

Goethe University

2